HK94096A - The use of certain calcium-citrate-malate for the manufacture of a medicament for the treatment of osteoporosis - Google Patents

The use of certain calcium-citrate-malate for the manufacture of a medicament for the treatment of osteoporosis

Info

Publication number
HK94096A
HK94096A HK94096A HK94096A HK94096A HK 94096 A HK94096 A HK 94096A HK 94096 A HK94096 A HK 94096A HK 94096 A HK94096 A HK 94096A HK 94096 A HK94096 A HK 94096A
Authority
HK
Hong Kong
Prior art keywords
malate
osteoporosis
treatment
citrate
medicament
Prior art date
Application number
HK94096A
Other languages
English (en)
Inventor
Barbara Ann Kochanowski
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Publication of HK94096A publication Critical patent/HK94096A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicinal Preparation (AREA)
HK94096A 1987-08-28 1996-05-30 The use of certain calcium-citrate-malate for the manufacture of a medicament for the treatment of osteoporosis HK94096A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9100687A 1987-08-28 1987-08-28

Publications (1)

Publication Number Publication Date
HK94096A true HK94096A (en) 1996-06-07

Family

ID=22225323

Family Applications (1)

Application Number Title Priority Date Filing Date
HK94096A HK94096A (en) 1987-08-28 1996-05-30 The use of certain calcium-citrate-malate for the manufacture of a medicament for the treatment of osteoporosis

Country Status (9)

Country Link
EP (1) EP0304986B1 (ko)
JP (1) JP2738541B2 (ko)
KR (1) KR970009582B1 (ko)
AT (1) ATE88633T1 (ko)
CA (1) CA1329774C (ko)
DE (1) DE3880587T2 (ko)
HK (1) HK94096A (ko)
IE (1) IE61451B1 (ko)
PH (1) PH25585A (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108761A (en) * 1990-10-01 1992-04-28 The Procter & Gamble Company Method of preventing tooth enamel erosion utilizing an acidic beverage containing calcium
JPH06502310A (ja) * 1990-10-31 1994-03-17 ザ、プロクター、エンド、ギャンブル、カンパニー カルシウム強化ソース
US5389387A (en) * 1991-12-26 1995-02-14 The Procter & Gamble Company Storage stable calcium-supplemented beverage concentrates
AU3240193A (en) * 1991-12-26 1993-07-28 Procter & Gamble Company, The Storage stable calcium-supplemented beverage concentrates
AU4597293A (en) * 1992-06-30 1994-01-24 Procter & Gamble Company, The Effervescent calcium supplements
EP0665720B1 (en) * 1992-10-21 1996-07-10 The Procter & Gamble Company Storage stable calcium-supplemented beverage premix concentrates and syrups
CA2146632C (en) * 1992-10-21 1999-02-23 Alice Lyles Burkes Sweetener containing a concentrated bioavailable calcium source
JP3199742B2 (ja) * 1992-10-21 2001-08-20 ザ、プロクター、エンド、ギャンブル、カンパニー 濃縮された生物学的利用性カルシウム源
IT1256300B (it) * 1992-11-05 1995-11-29 Dompe Farmaceutici Spa Uso di acidi aril-, eteroaril- e alchiltartronici come agenti terapeutici
JP2002525091A (ja) * 1998-09-29 2002-08-13 ザ プロクター アンド ギャンブル カンパニー 栄養性カルシウム源が補給された低酸性飲料
US6811800B2 (en) 1998-09-29 2004-11-02 The Procter & Gamble Co. Calcium fortified beverages
AU2007285386B2 (en) * 2006-08-17 2011-02-03 The Procter & Gamble Company Compositions comprising calcium citrate malate and methods for making the same
TR200908237A2 (tr) 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
WO2012125524A1 (en) * 2011-03-16 2012-09-20 The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Medical Center Compositions and methods for the treatment of musculoskeletal related diseases and disorders using metal ion-citrate analog complexes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5697248A (en) * 1979-12-28 1981-08-05 Tanaka Shiro Conjugated compound of calcium citrate and calcium malate and its preparation
FR2601249A1 (fr) * 1986-07-09 1988-01-15 Sandoz Lab Nouvelles compositions pharmaceutiques a base de sels de calcium.
US4786510A (en) * 1987-07-02 1988-11-22 The Procter & Gamble Company Calcium-iron mineral supplements

Also Published As

Publication number Publication date
JP2738541B2 (ja) 1998-04-08
ATE88633T1 (de) 1993-05-15
DE3880587D1 (de) 1993-06-03
KR890003390A (ko) 1989-04-14
IE61451B1 (en) 1994-11-02
IE882609L (en) 1989-02-28
KR970009582B1 (en) 1997-06-14
DE3880587T2 (de) 1993-09-23
JPH01151515A (ja) 1989-06-14
PH25585A (en) 1991-08-08
CA1329774C (en) 1994-05-24
EP0304986A2 (en) 1989-03-01
EP0304986B1 (en) 1993-04-28
EP0304986A3 (en) 1990-03-07

Similar Documents

Publication Publication Date Title
RU98111594A (ru) Фармацевтические композиции, включающие флурбипрофен
IL113651A0 (en) Pharmaceutical compositions containing alendronate and their use
HK94096A (en) The use of certain calcium-citrate-malate for the manufacture of a medicament for the treatment of osteoporosis
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
SG166294G (en) Inhalation medicaments for treating respiratory disorders
ATE289199T1 (de) Formulierungen mit dem wasserfreien mononatriumsalz von alendronat und deren verwendung zur behandlung von knochenkrankheiten
GB2235626B (en) Inhalation medicaments for treating respiratory disorders
IL87452A (en) Calcium citrate malate and calcium supplements containing it
DK0668077T3 (da) Produkter, som indeholder G-CSF og TNF-bindende protein
DE3685853D1 (de) Mittel zur behandlung von knochenkrankheiten.
ATE184788T1 (de) Idebenone-haltige zusammensetzungen zur behandlung von m. alzheimer
DE3879489D1 (de) Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie.
FR2635006B1 (fr) Medicament destine a regulariser les secretions hormonales et a traiter la sterilite

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20080814